Exosomes derived from bone marrow mesenchymal stem cells ameliorate chemotherapeutically induced damage in rats’ parotid salivary gland
Oral and Maxillofacial Surgery · 2025
DOI: 10.1007/s10006-025-01331-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oral and Maxillofacial Surgery, 2025. Verfasst von Ahmed Zakaria und 3 weiteren Autor:innen. Beteiligte Einrichtung: Egyptian Ministry of Health, Mansoura, Egypt. Hauptthemen laut MEDLINE: Exosomes, Parotid Gland, Mesenchymal Stem Cells, Mesenchymal Stem Cell Transplantation. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Mansoura University.
Abstract (Originalsprache)
Objective
A nanometer-sized vesicles originating from bone marrow mesenchymal stem cells (BMMSCs), called exosomes, have been extensively recognized. This study defines the impact of BMMSCs and their derived exosomes on proliferation, apoptosis and oxidative stress (OS) levels of CP-induced parotid salivary gland damage.
Methods
BMMSCs were isolated from the tibia of four white albino rats and further characterized by flowcytometric analysis. BMMSCs-derived exosomes were harvested and underwent characterization using transmission electron microscopy (TEM), western blot analysis and BCA assay. Fifty-six healthy white albino male rats weighting from 200 to 250 g were allocated into 4 groups ( n = 14); Group I, rats received phosphate buffered saline (PBS), group II, rats were intraperitoneally injected with CP, group III& IV received CP and after 3 days they were intravenously injected with either BMMSCs (group III) or BMMSCs-exosomes (group IV). Histological, and immunohistochemical studies using proliferating cell nuclear antigen (PCNA) were done after 7 and 14 days. The OS was measured using malondialdehyde (MDA) and apoptosis was measured by annexin V-FITC/PI.
Results
BMMSCs and exosomes treated groups showed better histological features approximating the normal architecture of the control group. The percentage of PCNA positively stained cells were significantly higher in the exosomes treated group in comparison to all other groups. MDA assay test revealed that the exosomes were able to reduce the OS when compared to the cell-based therapy using BMMSCs. Annexin V revealed that BMMSCs-exosomes significantly reduced the percentage of apoptotic cells compared to other treated groups.
Conclusions
BMMSCs-exosomes could improve the CP-induced cytotoxicity in rats’ parotid salivary gland.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Egyptian Ministry of Health, Mansoura, Egypt.
- Oral Biology, Faculty of Dentistry, Mansoura University, Mansoura, Egypt. nesmasultan@mans.edu.eg.
- Oral Biology and Dental Morphology, Faculty of Dentistry, Mansoura National University, Gamasa, Egypt. nesmasultan@mans.edu.eg.
- Oral Biology Department, Faculty of Dentistry, Mansoura University, Mansoura, Egypt.
- Oral Biology Department, Faculty of Dentistry, Egyptian Russian University, Cairo, Egypt.
ORCID-Profile: Nessma Sultan, Nesreen Nabil, Mahitabe Elgamily
Förderung
- Mansoura University
Zitieren
APA
Zakaria, A., Sultan, N., Nabil, N., & Elgamily, M. (2025). Exosomes derived from bone marrow mesenchymal stem cells ameliorate chemotherapeutically induced damage in rats’ parotid salivary gland. Oral and Maxillofacial Surgery. https://doi.org/10.1007/s10006-025-01331-9
Vancouver
Zakaria A, Sultan N, Nabil N, Elgamily M. Exosomes derived from bone marrow mesenchymal stem cells ameliorate chemotherapeutically induced damage in rats’ parotid salivary gland. Oral and Maxillofacial Surgery. 2025. doi:10.1007/s10006-025-01331-9
BibTeX
@article{Zakaria2025,
author = {Zakaria, Ahmed and Sultan, Nessma and Nabil, Nesreen and Elgamily, Mahitabe},
title = {Exosomes derived from bone marrow mesenchymal stem cells ameliorate chemotherapeutically induced damage in rats’ parotid salivary gland},
journal = {Oral and Maxillofacial Surgery},
year = {2025},
doi = {10.1007/s10006-025-01331-9}
}
EUVIMED